BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25169537)

  • 1. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
    Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
    Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
    Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
    Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.
    Pan F; Tian J; Pan YY; Zhang Y
    Mol Biol Rep; 2012 Jun; 39(6):7143-54. PubMed ID: 22311038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis.
    Umar M; Upadhyay R; Mittal B
    Tumour Biol; 2013 Dec; 34(6):3537-44. PubMed ID: 23797815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
    Chang K; Deng S; Lu W; Wang F; Jia S; Li F; Yu L; Chen M
    PLoS One; 2012; 7(7):e41519. PubMed ID: 22911807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between tumor necrosis factor β 252 A/G polymorphism and risk of gastric cancer: a meta-analysis.
    Xu Z; Shi R; Zhang R; Zhang D; Wang L
    Tumour Biol; 2013 Dec; 34(6):4001-5. PubMed ID: 23904263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis.
    Yu JY; Li L; Ma H; Liu K; Cheng X; Li YL; Song XL
    Tumour Biol; 2013 Dec; 34(6):3859-63. PubMed ID: 23900678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk.
    Tian X; Ma P; Sui C; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
    Tumour Biol; 2014 Jan; 35(1):103-9. PubMed ID: 23943369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
    Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
    Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PSCA polymorphisms derived from genome-wide association study are associated with risk of gastric cancer: a meta-analysis.
    Shi D; Wang S; Gu D; Wu D; Wang M; Chu H; Tong N; Ma L; Zhong D; Zhang Z
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1339-45. PubMed ID: 22481254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
    Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
    Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
    Guo R; Guo X
    Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
    Cheng K; Zhao YJ; Liu L; Wan JJ
    Asian Pac J Cancer Prev; 2013; 14(5):3275-9. PubMed ID: 23803115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.
    Da LS; Zhang Y; Zhang S; Qian YC; Zhang Q; Jiang F; Xu L
    PLoS One; 2013; 8(12):e82855. PubMed ID: 24367564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.
    Lu Y; Mo C; Zeng Z; Chen S; Xie Y; Peng Q; He Y; Deng Y; Wang J; Xie L; Zeng J; Li S; Qin X
    PLoS One; 2013; 8(12):e84413. PubMed ID: 24376807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
    Chen X; Mo W; Peng Q; Su X
    BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma.
    Zhao Y; Wang Q; Deng X; Shi P; Wang Z
    Tumour Biol; 2013 Aug; 34(4):2121-6. PubMed ID: 23765758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases.
    Gong WF; Zhong JH; Xiang BD; Ma L; You XM; Zhang QM; Li LQ
    PLoS One; 2013; 8(4):e60108. PubMed ID: 23565189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis.
    Wu Z; Wang H; Chu X; Chen J; Fang S
    Tumour Biol; 2013 Aug; 34(4):2147-52. PubMed ID: 23636796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.